RadarScreener › PMCB

PMCB

PharmaCyte Biotech, Inc.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1157075) · 1 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

Several filing signals but no multi-filing setup yet; see the timeline.

Radar 18 (low attention) · dilution pressure low · listing risk low · governance risk low · runway 43.9 mo · strongest signal: Near $5M MVLS floor (Apr 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

18Radar · attention score (0–100)
0Dilution pressure · financing + balance sheet
25Listing risk · exchange standards
0Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on PMCB
Alerts
One email the morning PMCB files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for PMCB back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$18.6Mcash + short-term investments as of Apr 30, 2026
43.9 moestimated runway (FY operating cash burn)
$33.3Mstockholders' equity as of Apr 30, 2026
$6.3Mpublic float (10-K cover)
10.7Mshares outstanding as of Jul 24, 2026 · was 10.7M Mar 12, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 108 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Apr 30, 2026 Near $5M MVLS floor Public float $6,278,282 (as of 2025-10-31) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing 25
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans